We rank companies based on fund manager, research analyst and news sentiment
HLTH stock icon

Cue Health Inc. Common Stock
HLTH

$0.16
2.82%
 

About: Cue Health Inc is a health technology company. It puts consumers in control of health information and places diagnostic information at the center of care. It enables people to manage their health through real-time, actionable and connected health data. Further, it offers individuals, enterprises, government agencies, and healthcare providers access to lab-quality diagnostic testing at home, at work, or at the point of care, all in a device that fits in the palm of hand. Its Cue Integrated Care Platform consists of multiple hardware, software, and diagnostic components and has been engineered so that it can be directly integrated into existing workflows and on-demand services, such as telemedicine, e-Rx services, and EMR systems.

Employees: 726

0
Funds holding %
of 6,474 funds
Analysts bullish %
News positive %

Fund manager confidence

Based on 2023 Q4 SEC filings by fund managers ($100M+ AUM)

4,472% more call options, than puts

Call options by funds: $75.8K | Put options by funds: $1.66K

0% more funds holding in top 10

Funds holding in top 10: 5 [Q3] → 5 (+0) [Q4]

3.41% less ownership

Funds ownership: 52.13% [Q3] → 48.72% (-3.41%) [Q4]

16% less funds holding

Funds holding: 73 [Q3] → 61 (-12) [Q4]

62% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 21

65% less capital invested

Capital invested by funds: $35.4M [Q3] → $12.2M (-$23.1M) [Q4]

71% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 17

Research analyst outlook

1 Wall Street Analyst provided 1 year price forecasts over the past 6 months

Low target
$0.5
208%
upside
Avg. target
$0.5
208%
upside
High target
$0.5
208%
upside

1 analyst rating

positive
0%
neutral
100%
negative
0%
Goldman Sachs
Matthew Sykes
208%upside
$0.5
Neutral
Maintained
10 Nov 2023

Financial journalist opinion